Continuum
Navigator
Sarah Mitchell, LCSW
Today — May 27
Your priority queue
Overdue
James R. Navigator check-in1d
Sandra T. Navigator check-in2d
Angela H. UDS follow-up1d
Scheduled Today
Maria B. Induction follow-up 10:00a
Robert P. Prescriber visit 11:30a
Chris W. Navigator check-in 2:00p
IOP Group A 6 members 4:00p
Needs Attention
James R. Missed IOP session (Fri)
Lisa T. Rx in-person due Jul 14
1 escalation pending review
8
Active members
3
In IOP phase
3
In maintenance
78% 90-day retention
vs. 48.4% national baseline · 65% program target
Nat'l 48.4%
Target 65%
Retained (Continuum) National baseline Program target
3
Overdue touchpoints
My Caseload
Member ▾ Phase Day Retention Next Touchpoint Risk Last Contact
JR
James R.
CTM-0041
 IOP Active 34
34 / 90 In progress
1d overdue High 3d ago
MB
Maria B.
CTM-0038
 Induction 3
3 / 90 Early
Today Med Today
DK
David K.
CTM-0035
 IOP Active 52
52 / 90 In progress
Tomorrow Low 1d ago
LT
Lisa T.
CTM-0029
 Maintenance 142
142 days 90 + ✓+52d
Jun 3 Low 5d ago
RP
Robert P.
CTM-0044
 Induction 1
1 / 90 Early
Tomorrow Med Today
ST
Sandra T.
CTM-0022
 Step-Down 98
98 days 90 + ✓+8d
2d overdue Med 4d ago
CW
Chris W.
CTM-0031
 IOP Active 41
41 / 90 In progress
May 29 Low Today
AH
Angela H.
CTM-0027
 Maintenance 178
178 days 90 + ✓+88d
1d overdue Med 8d ago
James R.
CTM-0041 · Acme Manufacturing · Day 34 · IOP Active
Current Outcomes
AUDIT-C
6
▼ 4 from intake
PHQ-9
12
▼ 3 from intake
GAD-7
9
— same
DAST-10
4
▼ 2 from intake
Episode Timeline
  • Apr 23, 2026
    Referral received from EAP (Acme Manufacturing)
  • Apr 24, 2026
    Intake assessment completed. ASAM Level 2.1. Assigned to S. Mitchell.
  • Apr 25, 2026
    Buprenorphine induction. 4mg initial, titrated to 16mg by Day 3. COWS 14 → 2.
  • May 2, 2026
    Stabilization confirmed. COWS 0. Dose stable at 16mg. Entered IOP.
  • May 9, 2026
    UDS: negative all panels, buprenorphine present. Attending 3x/wk IOP.
  • May 16, 2026
    Navigator check-in. Reports stable housing, returned to work. PHQ-9 improved to 12.
  • May 23, 2026
    Missed IOP session (Fri group). No call/no show.
    Auto-escalated. Outreach attempted same day, voicemail left.
  • May 27, 2026 (today)
    Navigator check-in due. Follow up on missed session.
  • May 28, 2026
    Prescriber visit scheduled. Dose review.
Prescribing
Buprenorphine/naloxone 16mg/4mg sublingual daily
Prescriber: Dr. K. Patel, NP · Open in EHR
Telehealth start: Apr 25, 2026 · In-person due by: Oct 22, 2026 · On track